New Analyses of Denosumab Pivotal Phase 3 Trials Reinforce Potential ... - PR Newswire (press release) Print
PR Newswire (press release)"Due to its strong efficacy profile, no need for renal monitoring, and convenient subcutaneous dosing, denosumab provides a significant improvement over the

... read more